Ph.D. thesis: „Antithrombotic effect of a monoclonal antibody against platelet glycoprotein IIb/IIIa receptor” 1992-1995, Leuven-Budapest
habilitation thesis: „Natural and arteficial antithrombotic mechanisms in arterial thrombosis”, 2011, Semmelweis University
Activities:
1981: medical doctor license number: 37530
Board certified: internal medicine, cardiology
1992-93: Ph.D. student, „free researcher” Center for Molecular and Vascular Biology, Catholic University, Leuven, Belgium (tutor: Professor Desiré Collen M.D. Ph.D.)
1994: visiting clinician, Thrombosis and Vascular Training Center, Division of Cardiovascular Diseases, Department of Internal Medicine, Mayo Clinic, Rochester, Minnesota, U.S.A. (Prof Walter Bowie M.D. Ph.D., John Heit M.D.)
2006 – 2022 Head, Chief Cardiologist, Dept. of Cardiology Military Hospital, Budapest (tertiary cardiovascular center, 1500 PCI, 1000 AMI, 1000 device implantation, 400 RF and cryoablation, TAVI, heart surgery)
2022-present Cardiologist, same workplace
2012 Honorary Professor of Medicine, Semmelweis University, Budapest, Hungary
Societies:
2001-2003: President, Hungarian Society of Thrombosis and Haemostasis
2013-2016: President, Hungarian Society of Cardiology
2011 – 2021 member, Council of Cardiology, Hungary
2016- 2018 member, Credentials Committee, ESC
Science:
1994 – present research, arterial thrombosis, clinical aspects
1997- referree, Thrombosis and Haemostasis, European Heart Journal
1998-present leader, Ph.D. theme program (thrombotic processes, antithrombotic effects in arterial thrombosis, five persons graduated), Semmelweis University
2006-present NLI of 19 TIMI studies and numeruous others
Scientific achievements
1992 fibrinolytic therapy activates protein-C by 100fold;
1993 a monoclonal antibody (later called abciximab) has antithrombotic properties in vivo;
2008 platelet alpha2 adrenergic receptor is partly responsible for the remaining platelet reactivity among DAPT-treated post ACS patients
